Featured Press Releases

AISA Pharma receives FDA orphan drug designation for AISA-021, a treatment for systemic sclerosis

AISA Pharma receives FDA orphan drug designation for AISA-021, a treatment for systemic sclerosis

MilliporeSigma receives the industry

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

  • 03 Sep 2024

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany,...

AusperBio

AusperBio's AHB-137 Receives Breakthrough Therapy Designation for Chronic Hepatitis B Treatment

Formosa Pharmaceuticals Strikes Licensing Deal with Tabuk Pharmaceuticals for Clobetasol Propionate Ophthalmic Suspension

Formosa Pharmaceuticals Strikes Licensing Deal with Tabuk Pharmaceuticals for Clobetasol Propionate Ophthalmic Suspension

Next Generation Gene Therapeutics (NGGT) announces the publication of early clinical trial results for NGGT001, a treatment for Bietti

Next Generation Gene Therapeutics (NGGT) announces the publication of early clinical trial results for NGGT001, a treatment for Bietti's Crystalline Dystrophy (BCD)

ENHERTU received U.S. approval for two new indications in HER2-positive early breast cancer.

ENHERTU received U.S. approval for two new indications in HER2-positive early breast cancer.

Packaging Compliance Labs enters pharmaceutical testing market with dedicated lab and expert leadership

Packaging Compliance Labs enters pharmaceutical testing market with dedicated lab and expert leadership

  • Packaging Compliance Labs
  • 30 Sep 2026
Ro and Novo announce research collaboration to generate first-of-its-kind real-world evidence on the Wegovy® pill

Ro and Novo announce research collaboration to generate first-of-its-kind real-world evidence on the Wegovy® pill

  • Ro
  • 30 Sep 2026
Cresilon launched next-generation TRAUMAGEL.

Cresilon launched next-generation TRAUMAGEL.

  • Cresilon
  • 29 Sep 2026
SHARx Focuses on Rx Continuity for Employers and Patients as Customs Requirements Change

SHARx Focuses on Rx Continuity for Employers and Patients as Customs Requirements Change

  • SHARx
  • 28 Sep 2026
Zifo Unveils Vision for an AI-Driven Scientific Semantic Layer in Biopharma

Zifo Unveils Vision for an AI-Driven Scientific Semantic Layer in Biopharma

  • Zifo
  • 28 Sep 2026
ImmunoScape Appoints Peter Olagunju as Chief Executive Officer

ImmunoScape Appoints Peter Olagunju as Chief Executive Officer

  • ImmunoScape Pte. Ltd.
  • 23 Sep 2026

Most Popular
October   2026
M T W T F S S
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.